Helios is a marker, not a driver, of human Treg stability
- 25 September 2021
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 52 (1) , 75-84
Abstract
Treg therapy holds promise as a potentially curative approach to establish immune tolerance in transplantation and autoimmune disease. An outstanding question is whether therapeutic Tregs have the potential to transdifferentiate into effector T‐cells and, thus, exacerbate rather than suppress immune responses. In mice, the transcription factor Helios is thought to promote Treg lineage stability in a range of inflammatory contexts. In humans, the role of Helios in Tregs is less clear, in part, due to the inability to enrich and study subsets of Helios‐positive versus Helios‐negative Tregs. Using an in vitro expansion system, we found that loss of high Helios expression and emergence of an intermediate Helios (Heliosmid)‐expressing population correlated with Treg destabilization. We used CRISPR/Cas9 to genetically ablate Helios expression in human naive or memory Tregs and found that Helios‐KO and unedited Tregs were equivalent in their suppressive function and stability in inflammation. Thus, high Helios expression is a marker, but not a driver, of human Treg stability in vitro. These data highlight the importance of monitoring Helios expression in therapeutic Treg manufacturing and provide new insight into the biological function of this transcription factor in human T‐cells.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Helios Induces Epigenetic Silencing of Il2 Gene Expression in Regulatory T CellsThe Journal of Immunology, 2013
- Phenotypic and Functional Properties of Helios+ Regulatory T CellsPLOS ONE, 2012
- Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansionBlood, 2012
- Helios Expression Is a Marker of T Cell Activation and ProliferationPLOS ONE, 2011
- Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune diseaseNature Medicine, 2011
- Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 DiabetesThe Journal of Immunology, 2011
- A role for the transcription factor Helios in human CD4+CD25+ regulatory T cellsMolecular Immunology, 2010
- Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory CellsThe Journal of Immunology, 2010
- GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3 + regulatory T cellsProceedings of the National Academy of Sciences, 2009
- Epigenetic Control of the foxp3 Locus in Regulatory T CellsPLOS Biology, 2007